FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+2.8%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$720M
AUM Growth
+$720M
(-6.4%)
Cap. Flow
-$31.7M
Cap. Flow
% of AUM
-4.4%
Top 10 Holdings %
Top 10 Hldgs %
45.97%
Holding
78
New
15
Increased
29
Reduced
14
Closed
5
Top Buys
| 1 |
ELGX
Endologix Inc
ELGX
|
$17.8M |
| 2 |
SI-BONE Inc
SIBN
|
$13.2M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$12.4M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$11.4M |
| 5 |
Codexis
CDXS
|
$8.88M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$46.8M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$18.3M |
| 3 |
Omnicell
OMCL
|
$16.4M |
| 4 |
Harvard Bioscience
HBIO
|
$13M |
| 5 |
Dynavax Technologies
DVAX
|
$12.5M |
Sector Composition
| 1 | Healthcare | 77.13% |
| 2 | Communication Services | 5.9% |
| 3 | Financials | 0.98% |
| 4 | Energy | 0.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $56.2M | 7.8% | 1,212,545 -1,009,176 | -45% | -$46.8M |
|
|
OXFD
2
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $43.2M | 6% | 3,140,347 +396,868 | +14% | +$5.46M |
|
|
MODN
3
DELISTED
MODEL N, INC.
MODN
| $42.5M | 5.9% | 2,178,520 +2,926 | +0.1% | +$57.1K |
|
4
AtriCure
ATRC
$1.84B
| $33.2M | 4.61% | 1,111,740 +197,433 | +22% | +$5.89M |
|
5
NeoGenomics
NEO
$1.13B
| $29.1M | 4.04% | 1,325,582 -279,029 | -17% | -$6.12M |
|
|
6
Omnicell
OMCL
$1.5B
| $28.5M | 3.96% | 331,462 -190,587 | -37% | -$16.4M |
|
|
MYOK
7
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $27M | 3.75% | 537,999 +98,364 | +22% | +$4.93M |
|
8
Nektar Therapeutics
NKTR
$568M
| $25.4M | 3.53% | 713,769 -49,634 | -7% | -$1.77M |
|
|
SPNE
9
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $23.9M | 3.31% | 1,800,997 +762 | +0% | +$10.1K |
|
|
10
Codexis
CDXS
$246M
| $22.2M | 3.08% | 1,205,523 +481,763 | +67% | +$8.88M |
|
|
11
Ionis Pharmaceuticals
IONS
$6.79B
| $21M | 2.92% | 327,132 -284,030 | -46% | -$18.3M |
|
12
Xencor
XNCR
$580M
| $20.4M | 2.84% | 499,344 -11,984 | -2% | -$491K |
|
13
Heron Therapeutics
HRTX
$207M
| $20.4M | 2.84% | 1,098,723 -14,243 | -1% | -$265K |
|
14
KORU Medical Systems
KRMD
$195M
| $19.8M | 2.75% | 6,884,200 | – | – |
|
15
Halozyme
HALO
$8.56B
| $18.3M | 2.55% | 1,067,813 -403,685 | -27% | -$6.94M |
|
|
ELGX
16
DELISTED
Endologix Inc
ELGX
| $17.8M | 2.48% | +2,462,448 | New | +$17.8M |
|
|
IMMU
17
DELISTED
Immunomedics Inc
IMMU
| $17M | 2.36% | 1,223,483 -181,230 | -13% | -$2.51M |
|
18
Veracyte
VCYT
$2.39B
| $16.8M | 2.33% | 589,099 -183,480 | -24% | -$5.23M |
|
|
XENT
19
DELISTED
Intersect ENT, Inc
XENT
| $15.2M | 2.11% | 668,893 -51,347 | -7% | -$1.17M |
|
20
Viatris
VTRS
$12.3B
| $14.2M | 1.97% | 743,784 +417,879 | +128% | +$7.96M |
|
|
AERI
21
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $14.1M | 1.96% | 478,174 +4,108 | +0.9% | +$121K |
|
|
22
SI-BONE Inc
SIBN
$719M
| $13.2M | 1.84% | +651,319 | New | +$13.2M |
|
|
23
Agios Pharmaceuticals
AGIO
$2.19B
| $12.4M | 1.72% | +247,897 | New | +$12.4M |
|
|
24
Ultragenyx Pharmaceutical
RARE
$2.89B
| $11.4M | 1.59% | +180,017 | New | +$11.4M |
|
|
VAPO
25
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $11.4M | 1.59% | 496,969 +97,977 | +25% | +$2.25M |
|